Breakthrough Victoria — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Cadmus is a university-partnered assessment platform for higher education that supports secure exams, collaborative tasks, academic integrity insights, and assisted marking.
EdTechSaaS
Herk Kailis(Founder)in
Co-investorsCardinia VenturesMelbourne Accelerator Program (MAP)SEEK InvestmentsEmerge EducationGlitch Capital
Eden Brew develops food and supplementation products designed to deliver nutrition in natural forms that align with how the human body processes nutrients, with a focus on sustainable scaling and long-term health support.
BiotechDeep TechFoodTechHealthtechImpact & Social Good
Jim Fader(Founder)in
Co-investorsMain Sequence VenturesDigitalis VenturesPossible VenturesRadar Ventures
Navi develops a medical device — an ECG-based catheter tip location system for newborn and pediatric patients — to help doctors and nurses in neonatal and pediatric intensive care units deliver better vascular access care.
Digital HealthHardwareHealthtechMedical DevicesMelbourne, AU
Alex Newton(CEO & Co-founder)inShing
BoardChristiane
Co-investorsArtesian
Quantum Brilliance develops integrated quantum microchips based on diamond nitrogen-vacancy centers for sensing and computing applications.
Deep TechHardwareQuantum ComputingSemiconductorsStuttgart, DE
Marcus Doherty(Founder)inMark Luo(Founder)inAndrew Horsley(Founder)
Co-investorsCP VenturesIn-Q-TelInterValley VenturesInvestible Climate Tech FundMain Sequence VenturesR&D Tax Incentive+6 more
Smileyscope develops virtual reality digital therapeutics for clinical procedures that reduce patient pain and anxiety without sedation.
Digital HealthHealthtechMedical DevicesAustin, US
Paul Leong(Executive Officer, Director)inEvelyn Chan(Executive Officer, Director)inNoah Rolland(Executive Officer, Director)in
BoardFred Toney(Director)
Co-investorsMelbourne Accelerator Program (MAP)Alice Anderson FundTen13
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















